## Most Common Reason for COC Discontinuation **Key Point:** Irregular bleeding and breakthrough bleeding (BTB) is the most frequent cause of discontinuation of combined oral contraceptive pills, accounting for approximately 10–15% of early discontinuations in clinical practice. ### Why Breakthrough Bleeding Occurs Breakthrough bleeding in COCs results from: - Insufficient endometrial proliferation due to low estrogen doses - Inadequate stabilization of the endometrium - Poor endometrial hemostasis - Occurs most commonly in the first 3–6 months of use ### Pattern of BTB with Different Formulations | Formulation Type | BTB Incidence | Mechanism | |---|---|---| | Traditional 30 µg EE | 10–15% | Estrogen threshold not met consistently | | Low-dose (<30 µg) | 15–20% | Insufficient endometrial support | | Ultra-low-dose (<20 µg) | 20–30% | Marginal endometrial proliferation | | Extended-cycle pills | Lower | Continuous endometrial stimulation | **Clinical Pearl:** Most cases of BTB resolve spontaneously by cycle 3–6. Reassurance and continuation are usually appropriate; switching to a higher-dose formulation is reserved for persistent, bothersome bleeding. **High-Yield:** Irregular bleeding is NOT a sign of contraceptive failure or a serious adverse effect—it is a dose-related, self-limiting phenomenon that is the leading cause of dissatisfaction and discontinuation. ### Management Approach 1. Counsel patient about natural resolution 2. Ensure correct pill-taking (same time daily) 3. Rule out infection (STI, candidiasis) 4. If persistent after 3 months: switch to 35 µg EE or extended-cycle formulation 5. Consider non-hormonal causes (thyroid disease, bleeding disorder) [cite:KD Tripathi 8e Ch 61]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.